Trial Profile

HIV vaccine trial capacity building in Tanzania and Mozambique by continued exploration of optimal DNA priming and MVA boosting strategies: TaMoVac II

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs HIV DNA vaccine; MVA HIV vaccine
Indications HIV-1 infections
Focus Adverse reactions; Pharmacodynamics
Acronyms TaMoVac-02; TaMoVac-II

Most Recent Events

29 Jun 2015 Biomarkers information updated
26 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
31 Dec 2012 New source identified and integrated (Pan-African Clinical Trials Registry record).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com